Distinguishing mechanisms of adverse drug reactions from mechanisms of actions of drugs
Distinguishing mechanisms of adverse drug reactions from mechanisms of actions of drugs |
|
https://doi.org/10.18632/oncotarget.25968
Ting-Hui Wu,
Nagla Karim,
and Jeffrey A. Moscow
|
| 32404-32405 |
Clinical utility of chromatin analysis
Clinical utility of chromatin analysis |
|
https://doi.org/10.18632/oncotarget.25991
Andreas Kleppe,
and Håvard E. Danielsen
|
| 32406-32407 |
An intestinal stem cell niche in Apc mutated neoplasia targetable by CtBP inhibition
An intestinal stem cell niche in Apc mutated neoplasia targetable by CtBP inhibition |
|
https://doi.org/10.18632/oncotarget.25784
Ayesha T. Chawla,
Agnes D. Cororaton,
Michael O. Idowu,
Priyadarshan K. Damle,
Barbara Szomju,
Keith C. Ellis,
Bhaumik B. Patel,
and Steven R. Grossman
|
| 32408-32418 |
A novel molecular mechanism for a long non-coding RNA PCAT92 implicated in prostate cancer
A novel molecular mechanism for a long non-coding RNA PCAT92 implicated in prostate cancer |
|
https://doi.org/10.18632/oncotarget.25940
Pushpinder Singh Bawa,
Samathmika Ravi,
Swagatika Paul,
Bibha Chaudhary,
and Subhashini Srinivasan
|
| 32419-32434 |
Integrin α2β1 decelerates proliferation, but promotes survival and invasion of prostate cancer cells
Integrin α2β1 decelerates proliferation, but promotes survival and invasion of prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.25945
Marjaana Ojalill,
Marjaana Parikainen,
Pekka Rappu,
Elina Aalto,
Johanna Jokinen,
Noora Virtanen,
Elina Siljamäki,
and Jyrki Heino
|
| 32435-32447 |
“Two hits - one stone”; increased efficacy of cisplatin-based therapies by targeting PCNA’s role in both DNA repair and cellular signaling
“Two hits - one stone”; increased efficacy of cisplatin-based therapies by targeting PCNA’s role in both DNA repair and cellular signaling |
|
https://doi.org/10.18632/oncotarget.25963
Caroline Krogh Søgaard,
Augun Blindheim,
Lisa M. Røst,
Voin Petrović,
Anala Nepal,
Siri Bachke,
Nina-Beate Liabakk,
Odrun A. Gederaas,
Trond Viset,
Carl-Jørgen Arum,
Per Bruheim,
and Marit Otterlei
|
| 32448-32465 |
SPIN1 is a proto-oncogene and SPIN3 is a tumor suppressor in human seminoma
SPIN1 is a proto-oncogene and SPIN3 is a tumor suppressor in human seminoma |
|
https://doi.org/10.18632/oncotarget.25977
Damian Mikolaj Janecki,
Marcin Sajek,
Maciej Jerzy Smialek,
Maciej Kotecki,
Barbara Ginter-Matuszewska,
Bogna Kuczynska,
Anna Spik,
Tomasz Kolanowski,
Riko Kitazawa,
Maciej Kurpisz,
and Jadwiga Jaruzelska
|
| 32466-32477 |
Zac1 regulates IL-11 expression in osteoarthritis
Zac1 regulates IL-11 expression in osteoarthritis |
|
https://doi.org/10.18632/oncotarget.25980
Chun-Lin Kuo,
Shu-Ting Liu,
Yung-Lung Chang,
Chia-Chun Wu,
and Shih-Ming Huang
|
| 32478-32495 |
Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cells
Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cells |
|
https://doi.org/10.18632/oncotarget.25985
Seiichi Okabe,
Tetsuzo Tauchi,
Yuko Tanaka,
and Kazuma Ohyashiki
|
| 32496-32506 |
miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro
miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro |
|
https://doi.org/10.18632/oncotarget.25986
Theresa Kordaß,
Claudia E.M. Weber,
David Eisel,
Antonino A. Pane,
Wolfram Osen,
and Stefan B. Eichmüller
|
| 32507-32522 |
Genomic mutations and histopathologic biomarkers in Y90 radioembolization for chemorefractory colorectal liver metastases
Genomic mutations and histopathologic biomarkers in Y90 radioembolization for chemorefractory colorectal liver metastases |
|
https://doi.org/10.18632/oncotarget.25992
Meaghan S. Dendy,
Johannes M. Ludwig,
Nima Kokabi,
Stacey M. Stein,
Jill Lacy,
Howard S. Hochster,
and Hyun S. Kim
|
| 32523-32533 |
Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer
Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer |
|
https://doi.org/10.18632/oncotarget.25946
Andrej Jedinak,
Kevin R. Loughlin,
and Marsha A. Moses
|
| 32534-32550 |
Retraction: MicroRNA-371-5p targets SOX2 in gastric cancer
Retraction: MicroRNA-371-5p targets SOX2 in gastric cancer |
|
https://doi.org/10.18632/oncotarget.26037
Yu-Ji Li,
Ming Dong,
Fan-Min Kong,
Jian-Ping Zhou,
Dong Liang,
and Huan-Zhou Xue
|
| 32551-32551 |
